Delivery Order 75F40121D00007-75F40123F19004
Award Date 7/24/23
Potential Completion Date 3/30/24
Potential Value $61K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $33,175 firm fixed price delivery order contract to Pacific Biosciences of California, Inc. for the purchase of reagents and supplies including AMPure PB, HiFi Express Template Prep Kit 2.0, Sequel Binding Kit 3.0, Sequel Sequencing Kit 3.0, and SMRT Cell 1M v3 LR Tray. The place of performance is Silver Spring, Maryland. The contract period runs from August 29, 2023 through March 30, 2024. As the prime...
- The Department of Health and Human Services Food and Drug Administration awarded a $43,337.06 firm fixed price delivery order to Pacific Biosciences of California, Inc. under the agency's indefinite-delivery/indefinite-quantity contract 75F40121D00007. The delivery order is for the purchase of specific supplies and reagents for use with Pacific Biosciences' PacBio Sequel IIE long-read DNA/RNA sequencer to support the FDA's regulatory science programs. Performance will occur in Laurel, Maryland...
- The Department of Health and Human Services Food and Drug Administration awarded a $51,193.93 purchase order to Pacific Biosciences of California, Inc. for sequencing supplies. The firm fixed price contract runs from August 23, 2023 to February 19, 2024 and will be performed by Pacific Biosciences in West Menlo Park, California. The original solicitation sought sequencing supplies as described in Combined Synopsis Solicitation 75F40123Q-117934 to support the FDA's evaluation of new sequencing...
- This is a delivery order awarded to Pacific Biosciences of California, Inc., a manufacturer of DNA/RNA sequencing systems and associated consumables, by the Department of Health and Human Services' Food and Drug Administration. The $69,567.00 firm-fixed-price order is for the provision of sequencing reagents, kits, and consumables to support the agency's genomic research initiatives. Pacific Biosciences has extensive experience providing specialized sequencing equipment and supplies to various...
- The Food and Drug Administration awarded a $22.9K firm fixed-price purchase order to Pacific Biosciences of California, Inc., a Menlo Park-based biotechnology manufacturer specializing in advanced DNA and RNA sequencing technologies. The award, designated as a total small business set-aside, was executed on July 27, 2021, for SMRT cell 8M trays and Sequel II sequencing kits—consumable products essential for next-generation sequencing operations. The procurement was completed ahead of the October...
- This contract award is for the purchase of reagents and supplies from Pacific Biosciences of California, Inc. by the U.S. Department of Health and Human Services' Food and Drug Administration. The items include PacBio's proprietary single molecule real-time (SMRT) sequencing consumables such as template prep kits, binding kits, and SMRT cells to support the agency's genomic research initiatives. The $46,548 firm-fixed price delivery order does not utilize a set-aside program. Pacific Biosciences...
- The U.S. Food and Drug Administration awarded a $48,715.20 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for Revio reagent kits (part number 102-817-900) with an ultimate completion date of September 9, 2024. This award represents a direct procurement of consumable supplies critical to next-generation DNA sequencing operations. Pacific Biosciences is a leading biotechnology manufacturer headquartered in Menlo Park, California, specializing in advanced sequencing...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a manufacturer of scientific equipment and reagents, for the provision of their Sequel and Sequel II DNA/RNA sequencing systems and associated consumables. The contract has a potential value of $197,441.19 and a completion date of October 12, 2017. Pacific Biosciences has fulfilled over $10 million in federal contracts with...
- The Department of Health and Human Services Food and Drug Administration awarded a $406,184 firm fixed price purchase order contract to Pacific Biosciences of California, Inc. for the provision of DNA sequencer and cluster generator hardware and software, as well as four annual preventative maintenance agreements to be exercised annually. The place of performance will be Laurel, Maryland and the period of performance is from September 26, 2023 through October 26, 2028. The contract was set aside...
- Pacific Biosciences of California, Inc. was awarded a $330,220.00 firm-fixed price purchase order by the Department of Health and Human Services Food and Drug Administration to provide a SEQUEL System with accessories, including shipping, training, and a 12-month manufacturer's warranty. The contract is set aside for small businesses. Pacific Biosciences is a manufacturer of scientific equipment, reagents, and services related to DNA/RNA sequencing systems, and has fulfilled over $10 million...